Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GRALthis companyGRAIL Inc.	$130.92	-7.7×	1.22×	21.37×	-7.92×	-125.0%	-42.5%	-363.0%	-277.5%	-15.8%	-14.3%	-9.5%	0.04×	0.4×	0×	11.97×	0.0%	4	7.44	2	C+
BLLNBillionToOne, Inc.	$113.55	1,284.77×	7.81×	12.29×	170.11×	1225.6%	68.3%	5.3%	2.4%	1.6%	2.6%	0.4%	0.23×	-19.59×	168.66×	11.69×	0.0%	7	17.31	3	B-
CSTLCastle Biosciences, Inc.	$32.57	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
FLGTFulgent Genetics, Inc.	$24.25	-13.34×	0.73×	2.51×	-16.71×	-77.3%	40.6%	-28.2%	-18.8%	-5.4%	-7.1%	-15.4%	0.01×	0.93×	-1,214.61×	6.48×	0.0%	5	4.47	3	B-
GHGuardant Health, Inc.	$157.35	-30.77×	-128.95×	13.04×	-37.81×	-214.8%	64.5%	-44.5%	-42.4%	419.2%	-25.1%	-1.8%	-17.22×	-3.56×	-112.2×	4.84×	0.0%	4	4.87	2	C
MYGNMyriad Genetics, Inc.	$5.77	-1.55×	1.56×	0.7×	-1.92×	-408.9%	69.9%	-8.2%	-44.4%	-99.4%	-10.8%	-4.5%	0.57×	-0.18×	-6.46×	2.49×	0.0%	4	-0.56	1	C-
Peer median	—	-13.34×	1.56×	3.28×	-1.92×	-214.8%	68.3%	-12.4%	-18.8%	-5.1%	-7.1%	-1.8%	0.08×	-3.56×	-112.2×	5.26×	0.0%	4	4.87	2	—